Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CHYM vs AFRM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CHYM
Chime Financial, Inc. Class A Common Stock

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$7.61B
5Y Perf.-44.9%
AFRM
Affirm Holdings, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$22.44B
5Y Perf.-2.6%

CHYM vs AFRM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CHYM logoCHYM
AFRM logoAFRM
IndustryBanks - RegionalSoftware - Infrastructure
Market Cap$7.61B$22.44B
Revenue (TTM)$2.19B$3.20B
Net Income (TTM)$-969M$382M
Gross Margin85.9%62.6%
Operating Margin-47.6%10.2%
Forward P/E112.9x62.5x
Total Debt$135M$7.85B
Cash & Equiv.$466M$1.35B

CHYM vs AFRMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CHYM
AFRM
StockJun 25May 26Return
Chime Financial, In… (CHYM)10055.1-44.9%
Affirm Holdings, In… (AFRM)10097.4-2.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: CHYM vs AFRM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: AFRM leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Chime Financial, Inc. Class A Common Stock is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CHYM
Chime Financial, Inc. Class A Common Stock
The Banking Pick

CHYM is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • beta 2.50
  • Lower volatility, beta 2.50, Low D/E 9.6%, current ratio 4.53x
  • Beta 2.50, current ratio 4.53x
Best for: income & stability and sleep-well-at-night
AFRM
Affirm Holdings, Inc.
The Growth Play

AFRM carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 38.8%, EPS growth 109.0%, 3Y rev CAGR 33.7%
  • -30.7% 10Y total return vs CHYM's -48.8%
  • 38.8% revenue growth vs CHYM's 30.7%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthAFRM logoAFRM38.8% revenue growth vs CHYM's 30.7%
ValueAFRM logoAFRMLower P/E (62.5x vs 112.9x)
Quality / MarginsAFRM logoAFRM11.9% margin vs CHYM's -46.2%
Stability / SafetyCHYM logoCHYMBeta 2.50 vs AFRM's 2.72, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)AFRM logoAFRM+30.7% vs CHYM's -48.8%
Efficiency (ROA)AFRM logoAFRM3.1% ROA vs CHYM's -49.8%, ROIC -0.7% vs -60.2%

CHYM vs AFRM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CHYMChime Financial, Inc. Class A Common Stock
FY 2025
Payments Revenue
100.0%$1.5B
AFRMAffirm Holdings, Inc.
FY 2025
Merchant Network
79.2%$883M
Virtual Card Network
20.8%$231M

CHYM vs AFRM — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAFRMLAGGINGCHYM

Income & Cash Flow (Last 12 Months)

AFRM leads this category, winning 3 of 4 comparable metrics.

AFRM and CHYM operate at a comparable scale, with $3.2B and $2.2B in trailing revenue. AFRM is the more profitable business, keeping 11.9% of every revenue dollar as net income compared to CHYM's -46.2%.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …
RevenueTrailing 12 months$2.2B$3.2B
EBITDAEarnings before interest/tax-$976M$533M
Net IncomeAfter-tax profit-$969M$382M
Free Cash FlowCash after capex$144M$787M
Gross MarginGross profit ÷ Revenue+85.9%+62.6%
Operating MarginEBIT ÷ Revenue-47.6%+10.2%
Net MarginNet income ÷ Revenue-46.2%+11.9%
FCF MarginFCF ÷ Revenue+1.5%+24.6%
Rev. Growth (YoY)Latest quarter vs prior year-65.8%
EPS Growth (YoY)Latest quarter vs prior year-35.0%
AFRM leads this category, winning 3 of 4 comparable metrics.

Valuation Metrics

AFRM leads this category, winning 3 of 5 comparable metrics.
MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …
Market CapShares × price$7.6B$22.4B
Enterprise ValueMkt cap + debt − cash$7.3B$28.9B
Trailing P/EPrice ÷ TTM EPS-7.15x449.07x
Forward P/EPrice ÷ next-FY EPS est.112.89x62.49x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple209.99x
Price / SalesMarket cap ÷ Revenue3.48x6.96x
Price / BookPrice ÷ Book value/share32.04x7.48x
Price / FCFMarket cap ÷ FCF231.45x37.29x
AFRM leads this category, winning 3 of 5 comparable metrics.

Profitability & Efficiency

AFRM leads this category, winning 5 of 8 comparable metrics.

AFRM delivers a 11.2% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-68 for CHYM. CHYM carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to AFRM's 2.56x. On the Piotroski fundamental quality scale (0–9), AFRM scores 6/9 vs CHYM's 3/9, reflecting solid financial health.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …
ROE (TTM)Return on equity-67.9%+11.2%
ROA (TTM)Return on assets-49.8%+3.1%
ROICReturn on invested capital-60.2%-0.7%
ROCEReturn on capital employed-78.1%-0.9%
Piotroski ScoreFundamental quality 0–936
Debt / EquityFinancial leverage0.10x2.56x
Net DebtTotal debt minus cash-$332M$6.5B
Cash & Equiv.Liquid assets$466M$1.4B
Total DebtShort + long-term debt$135M$7.9B
Interest CoverageEBIT ÷ Interest expense1.88x
AFRM leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

AFRM leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in AFRM five years ago would be worth $12,474 today (with dividends reinvested), compared to $5,123 for CHYM. Over the past 12 months, AFRM leads with a +30.7% total return vs CHYM's -48.8%. The 3-year compound annual growth rate (CAGR) favors AFRM at 78.0% vs CHYM's -20.0% — a key indicator of consistent wealth creation.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …
YTD ReturnYear-to-date-28.0%-9.0%
1-Year ReturnPast 12 months-48.8%+30.7%
3-Year ReturnCumulative with dividends-48.8%+464.2%
5-Year ReturnCumulative with dividends-48.8%+24.7%
10-Year ReturnCumulative with dividends-48.8%-30.7%
CAGR (3Y)Annualised 3-year return-20.0%+78.0%
AFRM leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CHYM and AFRM each lead in 1 of 2 comparable metrics.

CHYM is the less volatile stock with a 2.50 beta — it tends to amplify market swings less than AFRM's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AFRM currently trades 67.4% from its 52-week high vs CHYM's 42.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …
Beta (5Y)Sensitivity to S&P 5002.50x2.72x
52-Week HighHighest price in past year$44.94$100.00
52-Week LowLowest price in past year$16.17$42.09
% of 52W HighCurrent price vs 52-week peak+42.3%+67.4%
RSI (14)Momentum oscillator 0–10050.663.1
Avg Volume (50D)Average daily shares traded4.7M5.3M
Evenly matched — CHYM and AFRM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates CHYM as "Buy" and AFRM as "Buy". Consensus price targets imply 39.4% upside for CHYM (target: $27) vs 19.9% for AFRM (target: $81).

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$26.50$80.77
# AnalystsCovering analysts833
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+1.0%+1.1%
Insufficient data to determine a leader in this category.
Key Takeaway

AFRM leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallAffirm Holdings, Inc. (AFRM)Leads 4 of 6 categories
Loading custom metrics...

CHYM vs AFRM: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CHYM or AFRM a better buy right now?

For growth investors, Affirm Holdings, Inc.

(AFRM) is the stronger pick with 38. 8% revenue growth year-over-year, versus 30. 7% for Chime Financial, Inc. Class A Common Stock (CHYM). Affirm Holdings, Inc. (AFRM) offers the better valuation at 449. 1x trailing P/E (62. 5x forward), making it the more compelling value choice. Analysts rate Chime Financial, Inc. Class A Common Stock (CHYM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CHYM or AFRM?

On forward P/E, Affirm Holdings, Inc.

is actually cheaper at 62. 5x.

03

Which is the better long-term investment — CHYM or AFRM?

Over the past 5 years, Affirm Holdings, Inc.

(AFRM) delivered a total return of +24. 7%, compared to -48. 8% for Chime Financial, Inc. Class A Common Stock (CHYM). Over 10 years, the gap is even starker: AFRM returned -30. 7% versus CHYM's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CHYM or AFRM?

By beta (market sensitivity over 5 years), Chime Financial, Inc.

Class A Common Stock (CHYM) is the lower-risk stock at 2. 50β versus Affirm Holdings, Inc. 's 2. 72β — meaning AFRM is approximately 9% more volatile than CHYM relative to the S&P 500. On balance sheet safety, Chime Financial, Inc. Class A Common Stock (CHYM) carries a lower debt/equity ratio of 10% versus 3% for Affirm Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CHYM or AFRM?

By revenue growth (latest reported year), Affirm Holdings, Inc.

(AFRM) is pulling ahead at 38. 8% versus 30. 7% for Chime Financial, Inc. Class A Common Stock (CHYM). On earnings-per-share growth, the picture is similar: Affirm Holdings, Inc. grew EPS 109. 0% year-over-year, compared to -37. 2% for Chime Financial, Inc. Class A Common Stock. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CHYM or AFRM?

Affirm Holdings, Inc.

(AFRM) is the more profitable company, earning 1. 6% net margin versus -46. 2% for Chime Financial, Inc. Class A Common Stock — meaning it keeps 1. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AFRM leads at -2. 7% versus -47. 6% for CHYM. At the gross margin level — before operating expenses — CHYM leads at 85. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CHYM or AFRM more undervalued right now?

On forward earnings alone, Affirm Holdings, Inc.

(AFRM) trades at 62. 5x forward P/E versus 112. 9x for Chime Financial, Inc. Class A Common Stock — 50. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHYM: 39. 4% to $26. 50.

08

Which pays a better dividend — CHYM or AFRM?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is CHYM or AFRM better for a retirement portfolio?

For long-horizon retirement investors, Affirm Holdings, Inc.

(AFRM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Chime Financial, Inc. Class A Common Stock (CHYM) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AFRM: -30. 7%, CHYM: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CHYM and AFRM?

These companies operate in different sectors (CHYM (Financial Services) and AFRM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CHYM

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 15%
  • Gross Margin > 51%
Run This Screen
Stocks Like

AFRM

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CHYM and AFRM on the metrics below

Revenue Growth>
%
(CHYM: 30.7% · AFRM: -65.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.